NCT00552513已完成不适用
An International Randomised Trial of Early Versus Delayed Invasive Strategies in Patients With Non-ST Segment Elevation Acute Coronary Syndromes
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 3,031
- 试验地点
- 2
- 主要终点
- Composite of Death, Myocardial (re-) Infarction, or Stroke
研究概览
简要总结
The timing of intervention study is a prospective, randomized, international, multicentre comparison of the relative efficacy, safety, and cost effectiveness of a management strategy of coronary angiography and intervention performed within 24 hours of randomization versus delayed coronary angiography and intervention in patients after 36 hours with acute coronary syndromes (ACS).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 21 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients presenting or admitted to hospital with symptoms suspected to represent an acute coronary syndrome (unstable angina or MI without persistent ST elevation) i.e., clinical history consistent with new onset, or a worsening pattern, of characteristic ischemic chest pain or ischemic symptoms occurring at rest or with minimal activity (lasting longer than five minutes or requiring sublingual nitroglycerin for relief of the pain)
- •Able to randomise within 24 hours of the onset of the most recent episode of symptoms
- •At least two of the three following additional criteria:
- •Age more than or equal to 60 years
- •Troponin T or I or Creatine Kinase - Myocardial Bands (CK-MB) above the upper limit of normal for the local institution
- •ElectroCardioGram (ECG) changes compatible with ischemia (i.e., ST depression at least 1 mm in two contiguous leads or T wave inversion mroe than 3 mm or any dynamic ST shift or transient ST elevation)
- •Written informed consent dated and signed
排除标准
- •Age less than 21 years
- •Not a suitable candidate for revascularisation
- •Co-morbid condition with life expectancy less than six months
结局指标
主要结局
Composite of Death, Myocardial (re-) Infarction, or Stroke
时间窗: 180 days
次要结局
- Need for Mechanical or Pharmacological Coronary Revascularization (i.e. Thrombolysis, PCI, CABG) at Days 30, 90, and 180(180 days)
- In-hospital Major Bleeding(Hospital discharge)
- First Occurrence of Any Component of the Composite of Death, MI, or Refractory Ischemia(180 days)
- Stroke at 30 Days and 180 Days(180 days)
- Composite of Death, MI, Stroke, Refractory Ischemia or Repeat Revascularization at 180 Days(180 days)
研究者
研究点 (2)
Loading locations...
相似试验
Unknown
不适用
Compare Early With Deferred Invasive Strategy for STEMI Presenting 24-48 Hours From Symptom OnsetST-segment Elevation Myocardial Infarction (STEMI)NCT04575012Shanghai Zhongshan Hospital1,200
招募中
不适用
Clinical Trial to Compare Two Surgical Approaches to the CochleaCochlear ImplantsHearing Loss, SensorineuralNCT06453343Radboud University Medical Center50
已完成
3 期
Immediate Versus Deferred Androgen Deprivation Therapy,Goserelin for Recurrent Prostate Cancer After Radical RadiotherapyProstate CancerNCT00439751Ontario Clinical Oncology Group (OCOG)79
已完成
不适用
The Second Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage TrialIntracerebral HemorrhageStrokeHypertensionNCT00716079The George Institute2,839
已完成
不适用
OCS Liver PROTECT Trial: Preserving and Assessing Donor Livers for TransplantationLiver TransplantationLiver Preservation for TransplantNCT02522871TransMedics300